Orsolya Pipek

1.7k total citations
35 papers, 622 citations indexed

About

Orsolya Pipek is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Orsolya Pipek has authored 35 papers receiving a total of 622 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 15 papers in Molecular Biology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Orsolya Pipek's work include Cancer Immunotherapy and Biomarkers (7 papers), Lung Cancer Research Studies (7 papers) and Cancer Genomics and Diagnostics (7 papers). Orsolya Pipek is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Lung Cancer Research Studies (7 papers) and Cancer Genomics and Diagnostics (7 papers). Orsolya Pipek collaborates with scholars based in Hungary, Denmark and United States. Orsolya Pipek's co-authors include Zoltán Szállási, István Csabai, Dávid Szüts, Ádám Póti, Marcin Krzystanek, Charles Swanton, Dezső Ribli, Bernadett Szikriszt, Balázs Döme and Gábor Tusnády and has published in prestigious journals such as Nature Communications, Bioinformatics and PLoS ONE.

In The Last Decade

Orsolya Pipek

31 papers receiving 617 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Orsolya Pipek Hungary 15 296 295 183 174 67 35 622
Juhong Jiang China 15 349 1.2× 272 0.9× 97 0.5× 235 1.4× 52 0.8× 38 669
Guozhong Jiang China 15 405 1.4× 220 0.7× 243 1.3× 111 0.6× 124 1.9× 43 668
Kaiyan Yang China 16 437 1.5× 190 0.6× 315 1.7× 122 0.7× 59 0.9× 41 773
Khalil Choucair United States 12 337 1.1× 234 0.8× 124 0.7× 178 1.0× 34 0.5× 36 693
Kijong Yi South Korea 10 244 0.8× 204 0.7× 144 0.8× 115 0.7× 52 0.8× 12 578
Colette Bigosch Switzerland 8 324 1.1× 213 0.7× 241 1.3× 147 0.8× 35 0.5× 8 558
Maria Maddalena Tumedei Italy 15 165 0.6× 286 1.0× 213 1.2× 296 1.7× 64 1.0× 46 632
Gaia Giannone Italy 14 262 0.9× 341 1.2× 169 0.9× 109 0.6× 50 0.7× 32 740
Rosamaria Pinto Italy 16 408 1.4× 128 0.4× 274 1.5× 97 0.6× 124 1.9× 28 655
Maria Unni Rømer Denmark 15 397 1.3× 206 0.7× 244 1.3× 72 0.4× 126 1.9× 26 640

Countries citing papers authored by Orsolya Pipek

Since Specialization
Citations

This map shows the geographic impact of Orsolya Pipek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Orsolya Pipek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Orsolya Pipek more than expected).

Fields of papers citing papers by Orsolya Pipek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Orsolya Pipek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Orsolya Pipek. The network helps show where Orsolya Pipek may publish in the future.

Co-authorship network of co-authors of Orsolya Pipek

This figure shows the co-authorship network connecting the top 25 collaborators of Orsolya Pipek. A scholar is included among the top collaborators of Orsolya Pipek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Orsolya Pipek. Orsolya Pipek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pipek, Orsolya, János Fillinger, Krisztina Bogos, et al.. (2025). Diagnostic and prognostic relevance of inflammatory markers in surgically treated thymic epithelial tumors: An international multicenter study. Lung Cancer. 200. 108111–108111.
2.
Barták, Barbara Kinga, Zsófia Brigitta Nagy, Alexandra Kalmár, et al.. (2025). Examination of Genetic and Epigenetic Characteristics of Patients with Hyperhomocysteinemia Following High-Dose Folic Acid Consumption. Nutrients. 17(13). 2133–2133.
3.
Pipek, Orsolya, József Stéger, Krisztián Papp, et al.. (2024). Systematic detection of co-infection and intra-host recombination in more than 2 million global SARS-CoV-2 samples. Nature Communications. 15(1). 517–517. 12 indexed citations
4.
5.
Pipek, Orsolya, et al.. (2024). Biologically informed deep learning for explainable epigenetic clocks. Scientific Reports. 14(1). 1306–1306. 16 indexed citations
6.
Pipek, Orsolya, Laura Vízkeleti, Donát Alpár, et al.. (2023). The Driverless Triple-Wild-Type (BRAF, RAS, KIT) Cutaneous Melanoma: Whole Genome Sequencing Discoveries. Cancers. 15(6). 1712–1712. 6 indexed citations
7.
Pipek, Orsolya, Donát Alpár, Orsolya Rusz, et al.. (2023). Genomic Landscape of Normal and Breast Cancer Tissues in a Hungarian Pilot Cohort. International Journal of Molecular Sciences. 24(10). 8553–8553. 2 indexed citations
8.
Kalmár, Alexandra, Orsolya Galamb, Gitta Szabó, et al.. (2023). Patterns of Somatic Variants in Colorectal Adenoma and Carcinoma Tissue and Matched Plasma Samples from the Hungarian Oncogenome Program. Cancers. 15(3). 907–907. 5 indexed citations
9.
Megyesfalvi, Zsolt, János Fillinger, Orsolya Pipek, et al.. (2023). Comparative expression analysis of immune-related markers in surgically resected lung neuroendocrine neoplasms. Lung Cancer. 181. 107263–107263. 4 indexed citations
10.
Pipek, Orsolya, István Csabai, Ákos Nagy, et al.. (2023). Liquid biopsy-based monitoring of residual disease in multiple myeloma by analysis of the rearranged immunoglobulin genes–A feasibility study. PLoS ONE. 18(5). e0285696–e0285696. 4 indexed citations
11.
Kalmár, Alexandra, Barbara Kinga Barták, Zsófia Brigitta Nagy, et al.. (2022). Folic Acid Treatment Directly Influences the Genetic and Epigenetic Regulation along with the Associated Cellular Maintenance Processes of HT-29 and SW480 Colorectal Cancer Cell Lines. Cancers. 14(7). 1820–1820. 7 indexed citations
12.
Megyesfalvi, Zsolt, Judit Pápay, Ilona Kovalszky, et al.. (2021). EGFR variant allele frequency predicts EGFR-TKI efficacy in lung adenocarcinoma: a multicenter study. Translational Lung Cancer Research. 10(2). 662–674. 15 indexed citations
13.
Kalmár, Alexandra, Zsófia Brigitta Nagy, Barbara Kinga Barták, et al.. (2020). S-Adenosylmethionine Treatment of Colorectal Cancer Cell Lines Alters DNA Methylation, DNA Repair and Tumor Progression-Related Gene Expression. Cells. 9(8). 1864–1864. 18 indexed citations
14.
Pipek, Orsolya, Rita Lózsa, Dávid Szüts, et al.. (2019). PD-L1 Expression of Lung Cancer Cells, Unlike Infiltrating Immune Cells, Is Stable and Unaffected by Therapy During Brain Metastasis. Clinical Lung Cancer. 20(5). 363–369.e2. 29 indexed citations
15.
Póti, Ádám, Yonghong Xiao, Orsolya Pipek, et al.. (2018). Long-term treatment with the PARP inhibitor niraparib does not increase the mutation load in cell line models and tumour xenografts. British Journal of Cancer. 119(11). 1392–1400. 22 indexed citations
16.
Reiniger, Lilla, Katalin Fábián, Orsolya Pipek, et al.. (2018). Chemotherapy treatment is associated with altered PD-L1 expression in lung cancer patients. Journal of Cancer Research and Clinical Oncology. 144(7). 1219–1226. 60 indexed citations
17.
Pipek, Orsolya, Dezső Ribli, J. Molnár, et al.. (2017). Fast and accurate mutation detection in whole genome sequences of multiple isogenic samples with IsoMut. BMC Bioinformatics. 18(1). 73–73. 22 indexed citations
18.
Reiniger, Lilla, Katalin Fábián, Orsolya Pipek, et al.. (2017). Evaluating the significance of density, localization, and PD-1/PD-L1 immunopositivity of mononuclear cells in the clinical course of lung adenocarcinoma patients with brain metastasis. Neuro-Oncology. 19(8). 1058–1067. 37 indexed citations
19.
Szikriszt, Bernadett, Ádám Póti, Orsolya Pipek, et al.. (2016). A comprehensive survey of the mutagenic impact of common cancer cytotoxics. Genome biology. 17(1). 99–99. 128 indexed citations
20.
Zámborszky, Judit, Bernadett Szikriszt, Orsolya Pipek, et al.. (2016). Loss of BRCA1 or BRCA2 markedly increases the rate of base substitution mutagenesis and has distinct effects on genomic deletions. Oncogene. 36(6). 746–755. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juhong Jiang Breakdown of academic impact, for papers by Guozhong Jiang Breakdown of academic impact, for papers by Kaiyan Yang Breakdown of academic impact, for papers by Khalil Choucair Breakdown of academic impact, for papers by Kijong Yi Breakdown of academic impact, for papers by Colette Bigosch Breakdown of academic impact, for papers by Maria Maddalena Tumedei Breakdown of academic impact, for papers by Gaia Giannone Breakdown of academic impact, for papers by Rosamaria Pinto Breakdown of academic impact, for papers by Maria Unni Rømer
Rankless by CCL
2026